Heron Therapeutics | HRTX - 資産





資産 変化する 日付
ALKERMES USD 4.39B 135.05M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amarin USD 624.36M 21.4M 2026-06
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Emergent BioSolutions USD 1.82B 69.9M 2023-12
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
Insmed USD 2.1B 26.7M 2026-06
Ligand Pharmaceuticals USD 2.19B 653.77M 2026-06
Merck USD 129.8B 1.12B 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.24B 35.44M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
Veracyte USD 1.49B 49.97M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06